| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |